Highlights include clinical data from Phase 3 studies in Community Acquired Pneumonia (CABP) and microbiologic data from a Phase 2 study in nontuberculous mycobacterial pulmonary disease (NTM-PD) ...

Weave Bio raises $20M Series A to expand its AI-native platform that accelerates regulatory workflows for drug development.

The findings suggest that the acquisition of the modern NOVA1 variant may have protected us from the detrimental effects of lead, promoting complex language development and social cohesion. This could ...

Goldman Sachs Nasdaq-100 Premium Income ETF is an attractive investment to express the view of volatile and weakly performing ...

Investing strategies should focus on index funds, cyclical value stocks, and AI beneficiaries, including infrastructure and ...

No one enjoys eliminating employee perks, but sometimes it’s unavoidable. Start by weighing the cost and value of each benefit. You can make the call yourself as the business owner, or you can pull ...

When citizens know the truth, governments work better. When information flows freely, societies thrive. And when secrecy is replaced with sunlight, lives are saved. Credible information is a ...

Companies investing millions in generative AI may soon find themselves stalled—not by the technology’s limits, but by their people’s. As generative AI becomes more ubiquitous, a paradox has emerged: ...

Venue: Elizabeth Rose Conference Hall, United Nations University Headquarters, Japan / Zoom Webinar The United Nations Development Programme (UNDP) and the United Nations University (UNU) will co-host ...

Aug 20 (Reuters) - This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...